NPC Presents at #AMCPNexus
NPC’s research and leadership team will tackle topics impacting managed care pharmacists and is sponsoring opportunities for student networking and professional development.
During the Academy of Managed Care Pharmacy Nexus 2023, October 16 - 18 in Orlando, FL, the NPC leadership and research team will present on a number of topics that impact the work of managed care pharmacists and is proud to host both the Student Pharmacist & New Practitioner Networking Reception and the Student Leadership Academy events.
To learn more about AMCP Nexus 2023 and to register, visit their website.
Session Highlights
Tuesday, October 17 | 5 PM and 5:30 PM
Poster Session: Oncology Drug Development: A Drug-Level Analysis of Subsequent Indications
An important component of accelerating the development of cancer treatments for patients is identifying new indications for drugs that have already been evaluated for safety and efficacy through clinical trials and regulatory review. NPC Research Associate, James Motyka, PharmD, will describe historical trends in post-approval oncology drug development and discuss the impact the Inflation Reduction Act (IRA) will likely have on efforts to identify new cancer indications.
Tuesday, October 17 | 3:15 PM – 4:30 PM
Podium Session – Award-winning Research Supporting the Managed Care Pharmacy Research Agenda
NPC’s VP of Research, Rochelle Henderson, PhD will present research on the relationship between race/ethnicity, wage status and specialty medication among employees with autoimmune conditions, and discuss how findings can be used to inform efforts to promote health equity. The research was selected by AMCP and the AMCP Foundation as one of the top-rated abstracts aligned key research priorities.
Presenters:
Nicholas Friedlander, PharmD, Prime Therapeutics
Jane Ha, PharmD, MS, Cencora (formerly AmerisourceBergen/Xcenda)
Rochelle Henderson, PhD, National Pharmaceutical Council
Caitlin M. Sheetz, MPH, ADVI Health
Moderator:
Laura Happe, PharmD, MPH, University of Florida, Journal of Managed Care and Specialty Pharmacy
Tuesday, October 17 | 6:00 PM - 7:30 PM
NPC-Sponsored Event: Student Pharmacist & New Practitioner Networking Reception
NPC invites student and early career pharmacists to network with established managed care pharmacists who will share advice, career opportunities, and life experiences.
Wednesday, October 18 | 8:00 AM - noon
NPC-Sponsored Event: Student Leadership Academy
This year, NPC is sponsoring a new offering at AMCP, the Student Leadership Academy. The event will help equip students with the insights, best practices and tools they need to support their local AMCP chapter and promote professional development. The event is open to all students.
Wednesday, October 18, 2023 | 9:45 AM – 11:00 AM
Executive Financial Literacy: Focusing on Value and Actuarial Data
NPC's Chief Science Officer, Jon Campbell, PhD, will join a panel discussion to help managed care professionals identify the type of value and actuarial data that's most valuable in their work and factors that support a successful partnership with the actuarial team.
Faculty:
- Jonathan D. Campbell, PhD, Chief Science Officer, National Pharmaceutical Council
- Jeffrey D. Dunn, PharmD, MBA, President and CEO,Cooperative Benefits Group
- Gregory Warren, FSA, FCA, MAAA, Partner and Consulting Actuary, Axene Health Partners
Moderator:
- Kim A. Caldwell, RPh, Principal, Texas Star Healthcare Consulting, LLC
Wednesday, October 18 | 10:00 AM and 10:30 AM
Poster Session: Oncology Drug Development: A Drug-Level Analysis of Subsequent Indications
An important component of accelerating the development of cancer treatments for patients is identifying new indications for drugs that have already been evaluated for safety and efficacy through clinical trials and regulatory review. NPC Research Associate, James Motyka, PharmD, will describe historical trends in post-approval oncology drug development and discuss the impact the Inflation Reduction Act (IRA) will likely have on efforts to identify new cancer indications.
Thursday, October 19, 2023 | 8:30 AM – 9:45 AM
KEYNOTE – Understanding the 340B Program: Policy, Patients, and Practical Implications for Managed Care Pharmacists
Created in 1992 to help low-income and uninsured patients access prescription medicines, the 340B drug discount program now represents $100 billion in drug sales. NPC’s President and CEO, John M. O'Brien, PharmD, MPH will join a panel of experts to discuss the history and current controversies regarding the program, and what the issues mean for managed care pharmacists.
Panelists:
- Dave Lacknauth, PharmD, MBA, MS, Executive Director of Pharmacy Services, Broward Health
- Rory Martin, PhD, Senior Principal, IQVIA
- Donald E. Nichols, PhD, Principal, Health Policy and Systems Research, Genentech, Inc
- John M. O'Brien, PharmD, MPH, President & CEO, National Pharmaceutical Council
Moderator:
- Christina Barrington, PharmD, Vice President, Chief Pharmacy Officer, Priority Health
Learn more about the 340B Drug Discount Program
Check out NPC's information and resources related to the 340B program.
